Introduction

Biotechnology is the integration of natural science and engineering science to achieve the application of organisms, cells, parts thereof, and molecular analogues for products and services. In a broader sense, it encompasses any use of living organisms or their products to improve human life — from bread-making yeast to recombinant insulin.

Modern biotechnology specifically refers to techniques that allow scientists to manipulate genes directly, creating recombinant DNA (rDNA) — DNA molecules formed by joining DNA from two or more sources. This forms the core of Genetic Engineering, the most powerful tool in modern biology.

Historical milestones:

• 1953: Watson and Crick describe DNA double helix.
• 1970: Hamilton Smith isolates the first restriction endonuclease (\( Hind\text{II} \)) — the "molecular scissors".
• 1972: Paul Berg creates the first recombinant DNA molecule.
• 1973: Cohen and Boyer clone a gene in bacteria — birth of the biotechnology era.
• 1982: Humulin (recombinant human insulin) becomes the first rDNA-derived drug approved for human use.
• 1994: Flavr Savr tomato — first genetically modified food crop approved for sale.

Importance in NEET: Biotechnology is a consistent high-yield chapter, producing 3–4 questions annually. Standard questions focus on:

• Steps and tools of recombinant DNA technology (restriction enzymes, vectors, PCR, gel electrophoresis).
• Human insulin production using rDNA technology (Eli Lilly process: chains A and B).
• Bt crops — Cry genes, mechanism of action, specificity.
• Gene therapy (ADA deficiency as the classic example).
• Biosafety, biopiracy, and transgenic animals.

Learning Objectives

By the end of this chapter, you should be able to:

• Define biotechnology and distinguish traditional from modern biotechnology.
• Explain the principles of genetic engineering: restriction enzymes, vectors, cloning, and expression.
• Describe the steps involved in recombinant DNA technology in sequence.
• Explain the production of human insulin, vaccines, and gene therapy using rDNA technology.
• Describe Bt crops and the molecular mechanism by which Bt toxin kills insects.
• Discuss the role of transgenic animals in research.
• Define biopiracy and explain the ethical dimensions of biotechnology.

Prerequisites

Before starting, ensure you understand:

• DNA Structure and Replication: Double helix, base pairing, semiconservative replication (Unit 7: Genetics and Evolution).
• Transcription and Translation: How genes encode proteins via mRNA (Unit 7).
• Microbiology Basics: Structure of bacteria, plasmids, and bacteriophages (Unit 1: Diversity in Living World).

Big Picture

NEET Priority: Critical

Modern biotechnology rests on two fundamental principles:

1. Genetic engineering: Alteration/modification of the chemistry of genetic material (DNA/RNA) to add new functions or silence old ones.
2. Sterile environment: Maintenance of a contamination-free environment to enable growth of only desired microbes or cells.

5.1.1 Restriction Enzymes (Restriction Endonucleases)

• Function: Cut DNA at specific short nucleotide sequences called restriction sites (typically 4–8 bp palindromes), acting as "molecular scissors."
• Discovery: First isolated from bacteria (restrict bacteriophage DNA → hence "restriction" enzymes). Named by Smith and Nathans (Nobel Prize 1978).
• Palindromic sequences: The restriction site reads the same on both strands in the 5' → 3' direction. Example for EcoRI:

EcoRI cuts between G and A on both strands, generating sticky ends (single-stranded overhangs):

• Sticky ends vs. Blunt ends:
  • Sticky ends: Staggered cuts leave short single-stranded overhangs. Can anneal with complementary sticky ends → easier to join using DNA ligase.
  • Blunt ends: Straight cuts (e.g., SmaI: cuts CCC↓GGG → no overhang).
• Naming convention: Named from the organism: EcoRI → from Escherichia coli strain RY13; Hind III → from Haemophilus influenzae strain Rd.

5.1.2 Vectors

A vector is a DNA molecule used as a vehicle to carry foreign DNA into a host cell for cloning (amplification) or expression (protein production).

Essential features of a vector:

1. Origin of Replication (ori): Allows autonomous replication inside the host cell. Without ori, the vector cannot multiply.
2. Selectable Marker: Usually antibiotic resistance genes (e.g., ampicillin resistance, tetracycline resistance). Helps identify which cells have taken up the recombinant plasmid.
3. Cloning Sites (Multiple Cloning Site, MCS): Restriction sites where foreign DNA can be inserted (without disrupting the vector's function).

Types of Vectors:

5.1.3 Competent Host

• Bacteria do not naturally take up foreign DNA. They must be made competent — treated so that their cell wall becomes permeable to DNA.
• Methods:
  • Chemical method: \( \text{CaCl}_2 \) treatment increases permeability; then heat shock (42°C for 90 seconds) drives DNA inside.
  • Electroporation: Brief high-voltage electric pulses create temporary pores in the membrane.

5.1.4 Polymerase Chain Reaction (PCR)

• Purpose: Amplify a specific target DNA sequence (even from minute quantities) in vitro without using a living cell.
• Principle: Repeated cycles of denaturation, annealing, and extension using thermostable DNA polymerase (Taq polymerase from Thermus aquaticus).
• Steps (each cycle, ~30 cycles total):
  1. Denaturation: Heat to ~94°C — hydrogen bonds break, double-stranded DNA separates.
  2. Annealing: Cool to ~55°C — short oligonucleotide primers (specific to the target region) bind to complementary single strands.
  3. Extension: Raise to ~72°C — Taq polymerase extends primers, synthesizing new complementary DNA strands.
• Result: After 30 cycles, the target DNA is amplified approximately \( 2^{30} \approx 10^9 \) times.

5.1.5 Gel Electrophoresis

• Purpose: Separate DNA fragments by size; visualize and purify them.
• Medium: Agarose gel (a polysaccharide from red algae). DNA is negatively charged (phosphate backbone) → migrates toward the positive electrode.
• Result: Smaller fragments travel faster (move farther); larger fragments move slower.
• Fragments are stained with ethidium bromide (EtBr) and visualized under UV light as glowing orange bands.

NEET Priority: Critical — sequence of steps often directly tested

The complete process in order:

1. Isolation of genetic material (DNA): Extract DNA from source organism; treat with lysozyme (to break bacterial cell wall), protease (remove proteins), RNase (remove RNA).
2. Cutting of DNA: Treat with restriction enzyme that recognizes a specific palindromic site. The insert DNA and the vector are cut with the same restriction enzyme to generate compatible sticky ends.
3. Ligation: DNA Ligase joins the sticky ends of insert and vector → creating recombinant DNA. This forms the phosphodiester bond between the insert and vector backbone.
4. Transformation: Recombinant DNA is introduced into host cell (competent E. coli) by heat shock/electroporation.
5. Selection (Selectable Markers): Bacteria that have taken up the recombinant plasmid are identified. Classic method — insertional inactivation:
   • pBR322 has both ampicillin (\( amp^R \)) and tetracycline (\( tet^R \)) resistance genes.
   • Cloning site within the \( tet^R \) gene → successful insertion inactivates tetracycline resistance.
   • Transformants are plated on both ampicillin and tetracycline plates:
     • Grow on Amp plate but NOT on Tet plate → Recombinant (insert disrupted \( tet^R \)).
     • Grow on BOTH plates → Non-recombinant (no insert, \( tet^R \) intact).
6. Culturing and Expression: Selected recombinant bacteria are grown in large fermenters; the inserted gene is expressed (transcribed and translated) to produce the desired protein.
7. Purification: Protein is extracted and purified (downstream processing) for use.

NEET Priority: Very High

5.3.1 Human Insulin Production

• Before rDNA technology: Insulin was extracted from pig and cattle pancreas (slightly different amino acid sequence → caused immune reactions in some patients).
• rDNA approach (Eli Lilly, 1982 — marketed as Humulin):
  • Human insulin consists of two polypeptide chains: Chain A (21 amino acids) and Chain B (30 amino acids), linked by two disulfide bonds.
  • Sequences for chains A and B were chemically synthesized as DNA.
  • Each sequence was joined to the gene for beta-galactosidase (\( \beta-\text{gal} \)) in separate plasmids → introduced into E. coli.
  • E. coli produces fusion proteins (β-gal + insulin chain A and B separately).
  • Fusion proteins are treated with cyanogen bromide to cleave the β-gal part.
  • Purified chains A and B are combined in vitro → disulfide bonds form → functional human insulin (Humulin).

5.3.2 Genetically Engineered Vaccines

• Traditional vaccines: Whole killed or attenuated pathogen (risk of disease).
• Recombinant vaccines: Only a specific antigenic protein is produced → no risk:
  • Hepatitis B vaccine: Gene for Hepatitis B surface antigen (HBsAg) inserted into yeast cells (Saccharomyces cerevisiae); purified HBsAg protein is used as vaccine.
  • Advantage: Safer, can be produced in large quantities, no risk of infection.

5.3.3 Gene Therapy

• Definition: Correcting a genetic disorder by inserting functional copies of a defective gene into a patient's cells.
• First clinical trial: 1990 — Adenosine Deaminase (ADA) Deficiency (a form of Severe Combined Immunodeficiency, SCID).
  • ADA enzyme is required for the immune system to function.
  • ADA-SCID patients cannot produce functional lymphocytes → severely immunocompromised.
• Procedure:
  1. Lymphocytes are withdrawn from patient's blood.
  2. A functional ADA gene (cDNA) is introduced into lymphocytes using a retroviral vector.
  3. Genetically corrected lymphocytes are returned to the patient.
  4. Limitation: Not permanent; lymphocytes have a limited lifespan, so periodic gene transfer is needed. A permanent cure requires correction in bone marrow stem cells.

NEET Priority: Very High

5.4.1 Bt Toxin and Cry Genes

• Bt = Bacillus thuringiensis — a naturally occurring soil bacterium.
• Bt produces Cry proteins (crystal proteins) — insecticidal proteins encoded by cry genes (also written as crylAc, cryllAb, etc.).
• In normal form (inside Bt spores), Cry proteins are protoxins (inactive).

5.4.2 Mechanism of Bt Toxin Action

1. Insect larva ingests Bt toxin along with plant material.
2. The alkaline pH of the insect's gut (midgut) dissolves the protein crystals.
3. Gut proteases cleave the protoxin → active toxin.
4. Active toxin binds to specific receptor proteins on the midgut epithelial cells.
5. Creates pores in the epithelial cell membrane → cells swell and lyse.
6. Insect larva stops feeding and dies.

5.4.3 Specificity of Cry Proteins

Different cry genes produce toxins specific to different insect orders:

• CrylAc and CryIIAb: Effective against lepidopteran insects (moths and butterflies — e.g., bollworm, corn borer).
• CryIAb: Effective against coleopteran insects (beetles).
• CryIIIAb: Effective against dipteran insects (flies and mosquitoes).

5.4.4 GM Crops — Examples

• Bt cotton: Cry1Ac gene inserted → resistant to Pectinophora gossypiella (pink bollworm). Most widely planted GM crop in India.
• Bt corn (maize): CryIAb gene → resistant to European corn borer.
• Golden Rice: Engineered to produce beta-carotene (Vitamin A precursor) in the endosperm; addresses Vitamin A deficiency in developing countries.
• Flavr Savr Tomato: First approved GM food; contained an antisense RNA gene to delay ripening (longer shelf life).

5.4.5 RNA Interference (RNAi)

• A strategy for pest resistance that uses double-stranded RNA (dsRNA) complementary to an insect-specific mRNA.
• Example: Meloidogyne incognita (a root-knot nematode) parasite of tobacco plants.
• Tobacco plants were engineered to produce dsRNA specific to the nematode's genes.
• The dsRNA initiates RNAi within the nematode → silences the parasite's gene → nematode cannot survive → protection of the plant.

NEET Priority: Moderate

Transgenic animals are animals whose genome has been modified by introduction of a foreign (trans) gene.

Uses of Transgenic Animals:

1. Normal physiology and development: Study of gene regulation, growth factors. E.g., transgenic mice overexpressing growth hormone → giant mice.
2. Disease models: Transgenic mice carrying human disease genes to study Alzheimer's, cancer, cystic fibrosis → test treatments.
3. Pharmaceutical production (Pharming): "Molecular pharming" — producing biopharmaceutical proteins in animal milk. E.g., transgenic cow "Rosie" produced human protein-enriched milk containing human \( \alpha \)-lactalbumin (nutritionally superior for human infants).
4. Vaccine Safety Testing: Before vaccines are given to humans, transgenic animals with human-like immunity are used to test safety.
5. Chemical Safety Testing: Oncomouse (Harvard mouse) — transgenic mouse with human cancer genes — used for carcinogenicity testing of chemicals (replacing conventional long-term animal tests).

NEET Priority: Moderate

Biosafety Issues

• GEAC (Genetic Engineering Appraisal Committee): India's regulatory body (under MoEFCC) that approves large-scale use of GMOs and ensures biosafety.
• Concerns include:
  • Gene escape: Transgenes may spread to wild relatives via pollen, creating "superweeds."
  • Loss of biodiversity: GM monocultures can displace wild varieties.
  • Allergenicity: GM proteins might cause allergic reactions.
  • Antibiotic resistance transfer: Selectable marker (antibiotic resistance) genes from GM crops could theoretically transfer to gut bacteria.

Biopiracy

• Definition: Unauthorized exploitation of biological resources (plants, animals, microorganisms) and traditional knowledge of indigenous communities by corporations without proper consent or benefit-sharing.
• Examples:
  • Turmeric patent (1995): US patent granted on the use of turmeric for wound healing — challenged by India (CSIR); patent revoked (2001) because Indian traditional use is prior art.
  • Basmati rice patent: A US company claimed patent on a strain of basmati rice; India contested it.
  • Neem (Azadirachta indica): Patents were sought on neem-based biopesticides; challenged successfully by India and European NGOs.

Patents and Protection

• The Convention on Biological Diversity (CBD, 1992) recognizes national sovereignty over biological resources.
• TRIPS Agreement (WTO): Trade-Related Aspects of Intellectual Property Rights — governs patent protection globally; tension with CBD.
• Countries like India protect their traditional knowledge through the Traditional Knowledge Digital Library (TKDL) — database of documented traditional uses that can be used as prior art to reject biopiracy patents.

Formula Sheet

There are no mathematical formulas in this biology chapter. Key quantitative facts:

• PCR amplification: After 30 cycles, copies ≈ \( 2^{30} \approx 10^9 \).
• Human insulin — Chain A: 21 amino acids; Chain B: 30 amino acids.
• Bt cotton Cry gene: CrylAc effective against lepidopteran bollworms.

Formula Derivations

Not applicable. We instead provide a mechanistic summary of the PCR Cycle:

Cycle n produces \( 2^n \) copies of the target:

The exponential amplification \( 2^n \) arises because each new strand serves as a template in the next cycle, making the process geometrically explosive.

Unit Analysis

No SI units dominate this chapter; key biological measures include:

• DNA fragment size: Base pairs (bp) or kilobases (kb). Gel electrophoresis resolves fragments from ~100 bp to ~20 kb on standard agarose.
• PCR cycle temperature:
  • Denaturation: ~94°C.
  • Annealing: ~55°C (varies with primer \( T_m \)).
  • Extension: ~72°C (optimal for Taq polymerase).

Example 1 (Basic): Why does EcoRI produce sticky ends while SmaI produces blunt ends? Solution:

• EcoRI cuts at a staggered position within its recognition sequence (between G and A on both strands), leaving 4-nucleotide single-stranded 5'-overhangs (AATT on each strand). These overhangs are called sticky ends because they can form hydrogen bonds with complementary overhangs, facilitating ligation.
• SmaI cuts at the exact center of its recognition sequence (CCC↓GGG) — exactly in the middle of both strands simultaneously — leaving no single-stranded overhangs. These are blunt ends.
• Practical significance: Sticky ends make ligation more efficient and directional; blunt-end ligation is less efficient and non-directional.

Example 2 (Medium): A student inserts a foreign gene into the tetracycline resistance gene (\( tet^R \)) of plasmid pBR322. After transformation into E. coli, she plates the bacteria on:

• Plate A: Medium with ampicillin only.
• Plate B: Medium with ampicillin + tetracycline.

Which colonies on which plate are recombinants?

Solution:

1. Cells that did not take up any plasmid: Sensitive to ampicillin → die on both plates (not counted).
2. Cells that took up the non-recombinant plasmid (no insert): Have intact \( amp^R \) and intact \( tet^R \) → grow on both Plate A and Plate B.
3. Cells that took up the recombinant plasmid (insert in \( tet^R \)): Have intact \( amp^R \) but disrupted \( tet^R \) → grow on Plate A only (ampicillin only); die on Plate B (tetracycline kills them).

Conclusion: Colonies that grow on Plate A but NOT on Plate B are recombinants (insertional inactivation of \( tet^R \)).

Example 3 (Difficult): Explain the complete mechanism by which Bt cotton protects itself from bollworm attack at the molecular and cellular level.

Solution:

1. Genetic engineering step: The cry1Ac gene from Bacillus thuringiensis is isolated, combined with a plant promoter (e.g., CaMV 35S), and inserted into the cotton genome via Agrobacterium tumefaciens Ti-plasmid vector.
2. Protein production in the plant: Bt cotton cells express the cry1Ac gene and produce Cry1Ac protoxin (crystalline, inactive form).
3. Ingestion by bollworm larva: When Pectinophora gossypiella (pink bollworm) larva feeds on Bt cotton, it ingests the Cry1Ac protoxin.
4. Activation in the gut: The bollworm's midgut has an alkaline pH (~9.5), which solubilizes the protein crystals. Alkaline gut proteases then cleave the protoxin at specific sites, releasing the active Cry1Ac toxin (a smaller, soluble peptide fragment).
5. Receptor binding: The active toxin recognizes and binds with high specificity to glycoprotein receptor molecules on the luminal surface of midgut epithelial cells.
6. Pore formation and cell lysis: Bound toxin monomers oligomerize (assemble together) and insert into the membrane, forming transmembrane pores (ion channels). Water floods into the cells via osmosis, causing the epithelial cells to swell and lyse (burst).
7. Larva death: Destruction of the midgut epithelium prevents the larva from digesting or absorbing food → larva ceases feeding within hours and dies within 1–3 days.
8. Specificity (why harmless to humans): Cry1Ac toxin only activates in highly alkaline insect guts; human stomach is acidic (pH ~2) → protoxin is digested as an ordinary protein without activation. Also, the specific glycoprotein receptors are absent in mammalian gut cells.

Memory Techniques

• Steps of rDNA Technology — mnemonic "I Can Let Them Safely Express Products":
  • Isolate DNA → Cut with restriction enzyme → Ligate into vector → Transform into host → Select transformants → Express protein → Purify.
• Bt Toxin specificity acronym "LCD":
  • Lepidoptera (moths): Cry1Ac, CryIIAb.
  • Coleoptera (beetles): CryIAb.
  • Diptera (flies): CryIIIAb.
• Insertional Inactivation remember:
  • "Grow on Amp but not Tet → Recombinant" (insert killed the tet-resistance gene).
• ADA gene therapy: "All Deficient Aids" → ADA deficiency causes SCID (immune failure).
• Biopiracy examples "TBN": Turmeric, Basmati, Neem — three celebrated biopiracy cases India won.

Summary

Modern biotechnology uses genetic engineering (recombinant DNA technology) to manipulate genes for practical purposes. Tools include restriction endonucleases (molecular scissors that create sticky ends), vectors (plasmids, phages — carrying ori, selectable markers, cloning sites), PCR (in vitro exponential amplification using Taq polymerase in denature/anneal/extend cycles), and gel electrophoresis (size-based separation). rDNA technology proceeds: isolate → cut → ligate → transform → select → express → purify. Key health applications include human insulin production in E. coli (Humulin — chains A and B separately, then combined), recombinant Hepatitis B vaccine (HBsAg from yeast), and gene therapy for ADA-SCID. Agricultural applications include Bt crops (Cry proteins kill lepidopteran, coleopteran, or dipteran insects by forming pores in gut cells), Golden Rice (beta-carotene), and RNAi for nematode control. Transgenic animals serve as disease models, protein factories (pharming), and chemical safety testers. Ethical dimensions include GEAC oversight of GMOs, biopiracy (unauthorized exploitation of bioresources/traditional knowledge — turmeric, basmati, neem cases), and the TKDL database protecting India's traditional knowledge.

One-Page Revision

Tools of rDNA Technology:

• Restriction enzymes: Cut at palindromic recognition sites → sticky ends (staggered) or blunt ends.
• Vectors (pBR322): Must have ori, selectable marker, cloning sites.
• DNA Ligase: Joins sticky ends to create recombinant DNA.
• PCR: Denature (94°C) → Anneal primers (55°C) → Extend with Taq (72°C). 30 cycles → \( 2^{30} \) copies.
• Gel electrophoresis: Agarose, EtBr stain, UV light. Smaller DNA runs farther.

Steps of rDNA: Isolate → Cut → Ligate → Transform → Select → Express → Purify.

Insertional Inactivation (pBR322): Insert in tet\(^R\) → grows on Amp but not Tet → Recombinant.

Human Insulin (Humulin):

• Chains A (21 aa) and B (30 aa) separately made in E. coli as fusion proteins.
• Cyanogen bromide cleaves β-gal part.
• Chains joined in vitro with disulfide bonds.

Bt Crops:

• cry genes from B. thuringiensis → Cry protoxin in plant.
• Alkaline insect gut + proteases → active toxin.
• Binds gut epithelial receptors → pores → cell lysis → larva dies.
• CrylAc → Lepidoptera; CrylAb → Coleoptera; CryIIIAb → Diptera.

Gene Therapy: ADA-SCID → functional ADA gene in retroviral vector → into patient lymphocytes.

Biosafety: GEAC (India) regulates GMO releases.

Biopiracy: Turmeric, Neem, Basmati — TKDL protects traditional knowledge.

Mind Map

Chapter Cheat Sheet

Interlinking

• Backward Link: Biology Unit 7: Genetics and Evolution — The double helix structure, DNA replication, transcription, translation, and genetic code are the molecular foundations on which recombinant DNA technology is built.
• Forward Link: Biology Unit 10: Ecology and Environment — Biosafety concerns about GMOs (gene escape to wild populations, impact on biodiversity) are directly related to the ecological principles of population genetics and biodiversity conservation.
• Chemistry Link: Chemistry Unit 15: Polymers — Agarose gel (used in electrophoresis) is a polysaccharide polymer; the chemistry of disulfide bond formation (joining insulin A and B chains) is studied in biomolecule chemistry.

References & Quality Checklist

References:

• NCERT Biology Class XII, Chapter 11: "Biotechnology: Principles and Processes".
• NCERT Biology Class XII, Chapter 12: "Biotechnology and its Applications".
• NTA NEET (UG) Official Syllabus, Unit 9: Biotechnology and Its Applications.

Quality Checklist:

• All syllabus items covered: genetic engineering tools (restriction enzymes, vectors, PCR, gel electrophoresis), rDNA technology steps (isolation to purification), human insulin production, vaccines (HBsAg), gene therapy (ADA-SCID), Bt crops (cry genes, Cry toxin mechanism, specificity), transgenic animals, biosafety (GEAC), biopiracy (turmeric, neem, basmati), TKDL.
• All inline math uses \( ... \) and display uses $$ ... $$ delimiters. No single $ signs.
• Standard 18-section heading format applied.
• Solved examples and practice questions with detailed solutions.
• Mermaid diagrams included.